Medtronic (MDT) Tops Q4 EPS by 4c; guides below
Tweet
Share
E-mail
Get Alerts MDT Hot Sheet
Price: $90.65 -0.64%
EPS Growth %: +10.3%
Financial Fact:
Research and development expense: 373M
Today's EPS Names:
RIBT, INLB, FTXP, More
EPS Growth %: +10.3%
Financial Fact:
Research and development expense: 373M
Today's EPS Names:
RIBT, INLB, FTXP, More
Join SI Premium – FREE
Medtronic (NYSE: MDT) reported Q4 EPS of $1.62, $0.04 better than the analyst estimate of $1.58. Revenue for the quarter came in at $8.93 billion versus the consensus estimate of $8.82 billion.
GUIDANCE:
Medtronic sees FY2026 EPS of $5.50-$5.60, versus the consensus of $5.83. The company is guiding to FY26 organic revenue growth of approximately 5%.
For earnings history and earnings-related data on Medtronic (MDT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Anthropic Signs $35b Cloud Deal With Lambda In Texas: WSJ
- RBC Capital Starts Mettler-Toledo (MTD) at Sector Perform
- XPeng delivers 39,107 vehicles in August, up 4% year-over-year
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
